retatrutide effects clinical trials side 2025 Today's TRIUMPH-4 results are a clear signal: the next Retatrutide vs Mounjaro: A Doctor's

The subcutaneous layer at the abdomen becomes thinner as fat is lost, and a needle that was appropriate at a higher body weight may become too long as treatment progresses

NYSE: PFE has been trying to enter the weight-loss treatment trend dominated by GLP-1 drug makers like Ozempic and Wegovy makers Novo Nordisk A/ S NYSE: NVO and Mounjaro and Zepbound makers Eli Lilly & Co

Early Parkinsons trials have shown mixed results, and Alzheimers trials are In the intestine and joints, GLP-1 agonists reduce intestinal inflammation in colitis models and may benefit osteoarthritis by reducing synovitis and chondrocyte inflammation

Ive lost 9.8 lbs in 1st month with no noticeable side effects beyond some reflux (a little more than my normal)